Only if that fails will they try biologics, newer treatments that include monoclonal antibodies such as infliximab (Remicade).    From Wordnik.com.  [Medlogs - Recent stories] Reference

Quality of life assessment in IBD patients receiving infliximab therapy.    From Wordnik.com.  [IBD clinical studies: quality of life] Reference

Incidence of infusion reaction in pediatric patients receiving infliximab.    From Wordnik.com.  [Clinical studies: IBD treatment safety] Reference

Linear growth during infliximab therapy: Results of the REACH Multicenter Study.    From Wordnik.com.  [Abstracts] Reference

Quality of life assessment in pediatric inflammatory bowel disease patients receiving infliximab therapy.    From Wordnik.com.  [IBD clinical studies: quality of life] Reference

Data was collected from initial questionnaires completed by patients at the time of infliximab infusions.    From Wordnik.com.  [IBD clinical studies: quality of life] Reference

Another biologic, Remicade infliximab, is a close relative of Enbrel, as it also prevents TNF from creating excessive inflammation.    From Wordnik.com.  [Psoriasis Guru » Blog Archive » What Are Biologics (Biologic Drugs) and Are They an Effective Psoriasis Treatment?] Reference

To describe the reported quality of life of pediatric patients with inflammatory bowel disease (IBD) who receive infliximab therapy.    From Wordnik.com.  [IBD clinical studies: quality of life] Reference

Other TNF inhibitors that were released soon after Enbrel (after 1998) include Remicade (infliximab) and Humira (adalimumab), none of which have been as widely used as Enbrel.    From Wordnik.com.  [Psoriasis Guru » Blog Archive » What is Enbrel (Etanercept) and Is It an Effective Psoriasis Treatment?] Reference

In contrast to infliximab it does not mediate antibody-dependent cell lysis.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

Therapy with both etanercept and infliximab decreased the RANKL / OPG ratio.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

Three anti-TNF agents are registered for use in RA: etanercept, infliximab and adalimumab.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

This study included 728 patients who received either an inactive placebo or infliximab for.    From Wordnik.com. Reference

"Most patients should receive infliximab combination therapy as the most effective strategy.".    From Wordnik.com.  [Medicaid and Medicare] Reference

The trial was funded by Centocor Ortho Biotech, which markets infliximab, and Schering-Plough.    From Wordnik.com.  [Medlogs - Recent stories] Reference

Four of the 12 patients who were infliximab primary non-responders experienced complete fistula healing.    From Wordnik.com.  [Medlogs - Recent stories] Reference

WASHINGTON - Researchers have been successful in treating cystic fibrosis and Crohn's disease with infliximab.    From Wordnik.com.  [Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7] Reference

One-third were given infliximab alone, one-third received only azathioprine and one-third were treated with both.    From Wordnik.com.  [Medlogs - Recent stories] Reference

No changes regarding synovial OPGL expression were observed following treatment with either infliximab or etanercept.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

The 48 cases identified included 31 following infliximab use, 15 following etanercept use, and 2 following adalimumab use.    From Wordnik.com.  [PhysOrg.com - latest science and technology news stories] Reference

Therapy with both azathioprine and infliximab appears to be the treatment of choice if steroids are not effective, Sandborn said.    From Wordnik.com.  [Medlogs - Recent stories] Reference

We reported for the first time that etanercept, similarly to infliximab, induces a decrease in the number of synovial macrophages.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

The reporting rates for infliximab and etanercept were compared with the background cancer rate in the general pediatric population.    From Wordnik.com.  [PhysOrg.com - latest science and technology news stories] Reference

A research team led by Professor Gian Luigi de 'Angelis, reported the first case of a patient with CF and CD treated with infliximab.    From Wordnik.com.  [Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7] Reference

Efficacy of certolizumab pegol in Crohn's disease patients with secondary failure to infliximab is not affected by concomitant medications.    From Wordnik.com. Reference

In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active.    From Wordnik.com.  [Medlogs - Recent stories] Reference

Cimzia (R) shows duration of response up to week 26 in moderate to severe Crohn's patients who failed the intravenous infusion treatment infliximab.    From Wordnik.com.  [WN.com - Articles related to Is a Google search a political ad? States starting to consider campaign rules for Internet age] Reference

Evidence that anti tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages but not lymphocytes in RA joints.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

Adalimumab, which is marketed by Abbott under the brand name Humira, is the third TNF inhibitor, after infliximab and etanercept, to be approved by USFDA.    From Wordnik.com.  [DWS Full News Feed]

/PRNewswire/-- Data evaluating the efficacy and safety of STELARA ™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an.    From Wordnik.com.  [WN.com - Articles related to Asim won’t walk CM’s talk on industry] Reference

The terminal half-life is 8-9. 5 days, but only 25\% patients of those receiving 3mg / kg have undetectable levels of infliximab 8 weeks after administration.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

In this respect, treatment with either infliximab or etanercept was demonstrated to reduce serum COMP levels in both responders and non-responders to therapy (195).    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

We demonstrated that treatment with both etanercept and infliximab increased synovial apoptosis levels as evaluated by both single TUNEL and active caspase 3 staining.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

Slide 41: To test if the anti-TNF proapoptotic effect is a synovial restricted event we evaluated the effect of both etanercept and infliximab on PBMCs obtained from RA patients.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

This approach is sustained by a recent study in Crohn's disease demonstrating an increased level of apoptosis following 10 weeks of infliximab therapy compared to baseline (175).    From Wordnik.com.  [Recently Uploaded Slideshows] Reference